focus -WSS

focus

author：Wikipedia 2025-10-01 07:40:57 - browse：12

A hand in pink glove holds a blue rack that contains three tubes of blood samples — first opinion coverage from STAT — Joe Raedle/Getty Images

During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk a big game about making the process easier for the sites running the trials and the patients participating in them. Everyone from trial sponsors to the Food and Drug Administration has been quick to promise simpler processes, less hassle, and better experiences for everyone involved.

But look closer, and you’ll see that these grand promises often fall apart when sponsors implement complicated plans for collecting blood, tissue and other biospecimens and impossible processes for managing those samples. Behind all the talk and regulatory guidance, there’s a reluctance to change how these essential elements of clinical trial execution are handled, putting the very ideals that sponsors are trying to uphold at risk.

The concept of site and patient centricity frequently gets reduced to addressing only superficial gestures, such as committing to promptly paying sites for their work or using tablets for conducting patient surveys. But the essence of centricity extends far beyond these surface-level measures. It lies in addressing the unseen and unmentioned complexities of clinical trials and providing real solutions that focus on truly prioritizing the needs of trial sites and participants.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Chemotherapy before breast cancer surgery might fuel metastasis

WSS

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

HHS's proposed rule does nothing to address the climate crisis

Deliver public health messages at the right time

Bacterial infection may be ‘key event’ in endometriosis, study says

The creative science of coining drug names

Listen: Biogen's messy board & Laronde's data problem

entertainment

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Hollywood unions extend contract negotiations for actors

AltruBio raises $225 million to develop ulcerative colitis drug

The cancer drug shortage isn’t new — and neither are the solutions

Has Bernie Sanders reached the limit of his pharma bullying effort?

Psychedelics group wrestles with new pharma identity

AltruBio raises $225 million to develop ulcerative colitis drug

The high cost of giving birth even with insurance

Novel spinal cord stimulator treats paralysis without surgery

Peter Hotez and the public health issue of online harassment

Listen: PBM conflicts, RSV vaccines, & the future of flu season

leisure time

Crowdfunding for medical bills sidesteps core problem, author says

4th of July breaks record for highest global temperature ever measured

A new study asks: Are we harming blood donors by taking blood?

PBM executives asked to testify by House panel

Can gargling with Listerine treat gonorrhea of the mouth?

As health system earnings go up, health insurance stocks go down

explore

explore

entertainment

leisure time